Drugs / PRO-148
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01541891 | Oct 2011 → Mar 2012 | dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01657253 | Nov 2013 → Feb 2015 | dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO-148 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01657253 ↗ |
| Route | Other | “PRO-148 applied in ocular surface of patients with mild to moderate dry eye syndrome q.i.d. for 60 days” NCT01541891 ↗ |